Boiron SA is a drug manufacturer that focuses on homeopathic products... Show more
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBCGX | 39.28 | 0.42 | +1.08% |
Fidelity Blue Chip Growth K6 | |||
FESMX | 11.90 | 0.09 | +0.76% |
First Eagle U.S. SMID Cap Opportunity I | |||
VLAIX | 42.71 | 0.32 | +0.75% |
Value Line Asset Allocation Instl | |||
CMUAX | 14.03 | 0.07 | +0.50% |
Columbia Select Mid Cap Value A | |||
DBOZX | 24.66 | 0.12 | +0.49% |
BNY Mellon Balanced Opportunity Z |
A.I.dvisor tells us that BOIRF and ELAN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOIRF and ELAN's prices will move in lockstep.
Ticker / NAME | Correlation To BOIRF | 1D Price Change % | ||
---|---|---|---|---|
BOIRF | 100% | N/A | ||
ELAN - BOIRF | 24% Poorly correlated | -0.54% | ||
BUDZ - BOIRF | 7% Poorly correlated | -2.88% | ||
BIOVF - BOIRF | 1% Poorly correlated | N/A | ||
ARSUF - BOIRF | 1% Poorly correlated | N/A | ||
CAIHF - BOIRF | 0% Poorly correlated | N/A | ||
More |